The report presents a summary of reimbursement situation for total and partial hip replacement in Europe. The following indications will be considered: coxarthrosis, osteonecrosis. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.